内容へ

胸部心臓血管外科

抗凝固療法の管理と中和

Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis. (新しいタブで開く)

Chai-Adisaksopha C, Hillis C, Siegal DM, Movilla R, Heddle N, Iorio A, Crowther M.

出典‎: Thromb Haemost 2016;116(5):879-90.

インデックス‎: PubMed 27488143

DOI‎: 10.1160/TH16-04-0266

https://www.ncbi.nlm.nih.gov/pubmed/27488143 (新しいタブで開く)

Reversal of warfarin: case-based practice recommendations. (新しいタブで開く)

Garcia DA, Crowther MA.

出典‎: Circulation 2012;125(23):2944-7.

インデックス‎: PubMed 22689931

DOI‎: 10.1161/CIRCULATIONAHA.111.081489

https://www.ncbi.nlm.nih.gov/pubmed/22689931 (新しいタブで開く)

Stopping antiplatelet medication before coronary artery bypass graft surgery: is there an optimal timing to minimize bleeding? (新しいタブで開く)

Gielen CL, Bruggemans EF, Stijnen T, Eikenboom J, Tavilla G, Brand A, Klautz RJ.

出典‎: Eur J Cardiothorac Surg 2015;48(4):e64-70.

インデックス‎: PubMed 26248820

DOI‎: 10.1093/ejcts/ezv269

https://www.ncbi.nlm.nih.gov/pubmed/26248820 (新しいタブで開く)

Is a fully heparin-bonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit? (新しいタブで開く)

Mahmood S, Bilal H, Zaman M, Tang A.

出典‎: Interact Cardiovasc Thorac Surg 2012;14(4):406-14.

インデックス‎: PubMed 22228288

DOI‎: 10.1093/icvts/ivr124

https://www.ncbi.nlm.nih.gov/pubmed/22228288 (新しいタブで開く)

Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes. (新しいタブで開く)

Mangoush O, Purkayastha S, Haj-Yahia S, Kinross J, Hayward M, Bartolozzi F, Darzi A, Athanasiou T.

出典‎: Eur J Cardiothorac Surg 2007;31(6):1058-69.

インデックス‎: PubMed 17306555

DOI‎: 10.1016/j.ejcts.2007.01.029

https://www.ncbi.nlm.nih.gov/pubmed/17306555 (新しいタブで開く)

Heparin-coated extracorporeal circulation in combination with low dose systemic heparinization reduces early postoperative blood loss in cardiac surgery. (新しいタブで開く)

Mirow N, Zittermann A, Koertke H, Maleszka A, Knobl H, Coskun T, Kleesiek K, Koerfer R.

出典‎: J Cardiovasc Surg (Torino) 2008;49(2):277-84.

インデックス‎: PubMed 18431350

https://www.ncbi.nlm.nih.gov/pubmed/18431350 (新しいタブで開く)

Idarucizumab for dabigatran reversal. (新しいタブで開く)

Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Levy JH, Sellke FW, Stangier J, Steiner T, Wang B, Kam CW, Weitz JI.

出典‎: N Engl J Med 2015;373(6):511-20.

インデックス‎: PubMed 26095746

DOI‎: 10.1056/NEJMoa1502000

https://www.ncbi.nlm.nih.gov/pubmed/26095746 (新しいタブで開く)

Idarucizumab for dabigatran reversal - full cohort analysis. (新しいタブで開く)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

出典‎: N Engl J Med 2017;377(5):431-41.

インデックス‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (新しいタブで開く)

Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. (新しいタブで開く)

Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG.

出典‎: J Cardiothorac Vasc Anesth 2007;21(6):851-4.

インデックス‎: PubMed 18068065

DOI‎: 10.1053/j.jvca.2007.05.009

https://www.ncbi.nlm.nih.gov/pubmed/18068065 (新しいタブで開く)

Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. (新しいタブで開く)

Sarode R, Milling TJ Jr, Refaai MA, Mangione A, Schneider A, Durn BL, Goldstein JN.

出典‎: Circulation 2013;128(11):1234-43.

インデックス‎: PubMed 23935011

DOI‎: 10.1161/CIRCULATIONAHA.113.002283

https://www.ncbi.nlm.nih.gov/pubmed/23935011 (新しいタブで開く)

Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. (新しいタブで開く)

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, Chen M, Qi J, Li L.

出典‎: JAMA Surg 2013;148(6):538-47.

インデックス‎: PubMed 23426385

DOI‎: 10.1001/jamasurg.2013.1560

https://www.ncbi.nlm.nih.gov/pubmed/23426385 (新しいタブで開く)

Andexanet alfa for the reversal of Factor Xa inhibitor activity. (新しいタブで開く)

Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, Mathur VS, Castillo J, Bronson MD, Leeds JM, Mar FA, Gold A, Crowther MA.

出典‎: N Engl J Med 2015;373(25):2413-24.

インデックス‎: PubMed 26559317

DOI‎: 10.1056/NEJMoa1510991

https://www.ncbi.nlm.nih.gov/pubmed/26559317 (新しいタブで開く)

Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. (新しいタブで開く)

Warkentin TE, Margetts P, Connolly SJ, Lamy A, Ricci C, Eikelboom JW.

出典‎: Blood 2012;119(9):2172-4.

インデックス‎: PubMed 22383791

DOI‎: 10.1182/blood-2011-11-393587

https://www.ncbi.nlm.nih.gov/pubmed/22383791 (新しいタブで開く)

Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting. (新しいタブで開く)

Øvrum E, Tangen G, Tølløfsrud S, Skeie B, Ringdal MA, Istad R, Øystese R.

出典‎: J Thorac Cardiovasc Surg 2011;141(5):1145-9.

インデックス‎: PubMed 20709334

DOI‎: 10.1016/j.jtcvs.2010.07.003

https://www.ncbi.nlm.nih.gov/pubmed/20709334 (新しいタブで開く)